A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction

Medical Hypotheses

Volumn 74, Issue 3, 2010, Pages 555-563

  Kinney, Dennis K ^a,b   Hintz, Kathryn ^a   Shearer, Erika M ^a   Barch, Daniel H ^a   Riffin, Catherine ^a   Whitley, Katherine ^a   Butler, Robert ^a  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYTOKINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADJUVANT THERAPY; ARTICLE; BRAIN ATROPHY; BRAIN DYSFUNCTION; CLIMATE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FETAL MALNUTRITION; GENETIC RISK; HUMAN; IMMUNE DYSREGULATION; IMMUNOCOMPETENCE; INTRAUTERINE INFECTION; MENTAL DISEASE; MENTAL STRESS; NEUROLOGIC DISEASE; NONHUMAN; ONSET AGE; PERINATAL INFECTION; PRENATAL CARE; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; RISK FACTOR; SCHIZOPHRENIA; SOCIAL STATUS; STRESS;

BRAIN DISEASES; CLIMATE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; INFECTION; MODELS, IMMUNOLOGICAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUBERTY; SCHIZOPHRENIA; STRESS, PSYCHOLOGICAL;

EID: 77649271275     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.09.040     Document Type: Article

References (136)

1. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006, 32(2):200-202.
2. Mednick S.A., Huttunen M.O., Machon R.A. Prenatal influenza infections and adult schizophrenia. Schizophr Bull 1994, 20(2):263-267.
3. Huttunen M.O., Niskanen P. Prenatal loss of father and psychiatric disorders. Arch Gen Psychiat 1978, 35(4):429-431.
4. Malaspina D., Corcoran C., Kleinhaus K.R., Perrin M.C., Fennig S., Nahon D. Acute maternal stress in pregnancy, schizophrenia in offspring: a cohort prospective study. BMC Psychiat 2008, 8:71.
5. van Os J., Selten J.P. Prenatal exposure to maternal stress and subsequent schizophrenia: the May 1940 invasion of the Netherlands. Br J Psychiat 1998, 172:324-326.
6. Clair D., Xu M., Wang P., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. Obstet Gynecol Surv 2006, 61(1):2-3.
7. Susser E., Hoek H.W., Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am J Epidemiol 1998, 147(3):213-216.
8. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiat 2002, 159(7):1080-1092.
9. McNeil T.F., Cantor-Graae E., Weinberger D.R. Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiat 2000, 157(2):203-212.
10. Castle D., Sham P., Murray R. Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 1998, 33(3):179-183.
11. Aleman A., Kahn R.S., Selten J.P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiat 2003, 60(6):565-571.
12. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005, 2(5):e141.
13. Torrey E.F. Prevalence studies in schizophrenia. Br J Psychiat 1987, 150:598-608.
14. Ingraham L.J., Kety S.S. Adoption studies of schizophrenia. Am J Med Genet 2000, 97:18-22.
15. Matthysse S., Holzman P.S., Gusella J.F., et al. Linkage of eye movement dysfunction to chromosome 6p in schizophrenia: additional evidence. Am J Med Genet B 2004, 128B:30-36.
16. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiat 2003, 60:1187-1192.
17. Torrey E.F., Yolken R.H. Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003, 9(11):1375-1380.
18. Müller N., Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 2006, 10(2):131-148.
19. Kinney D.K., Teixeira P., Hsu D., Napoleon S.C., Crowley D.J., Miller A., et al. Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin D deficiency and infections?. Schizophr Bull 2009, 35(3):582-595.
20. Moore S.E., Cole T.J., Collinson A.C., Poskitt E.M., McGregor I.A., Prentice A.M. Prenatal or early postnatal events predict infectious deaths in young adulthood in rural Africa. Int J Epidemiol 1999, 28(6):1088-1095.
21. Moore S.E., Cole T.J., Poskitt E.M., Sonko B.J., Whitehead R.G., McGregor I.A., et al. Season of birth predicts mortality in rural Gambia. Nature 1997, 388(6641):434.
22. Barker D.J.P. Mothers, babies, and health in later life 1998, Churchill Livingstone, Edinburgh.
23. Barker D.J.P. Fetal and infant origins of adult disease. Monatsschr Kinderheilkd 2001, 149(Suppl. 1):S2-S6.
24. Osmond C., Barker D.J. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 2000, 108(Suppl. 3):545-553.
25. Steinmann G.G., Klaus B., Muller-Hermelink H.K. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985, 22(5):563-575.
26. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev 2000, 31:251-269.
27. Kunugi H., Nanko S., Murray R.M. Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br J Psychiat 2001, 40(Suppl.):s25-s29.
28. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 2000, 12:501-527.
29. Schmidt-Kastner R., van Os J., Steinbusch H.W.M., Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 2006, 84:253-271.
30. Coe C.L., Lubach G.R., Karaszewski J.W., Ershler W.B. Prenatal endocrine activation alters postnatal cellular immunity in infant monkeys. Brain Behav Immun 1996, 10(3):221-234.
31. Erickson K.L., McNeill C.J., Gershwin M.E., Ossmann J.B. Influence of dietary fat concentration and saturation on immune ontogeny in mice. J Nutr 1980, 110(8):1555-1572.
32. Luster M.I., Faith R.E., Kimmel C.A. Depression of humoral immunity in rats following chronic developmental lead exposure. J Environ Pathol Toxicol 1978, 1(4):397-402.
33. Sobrian S.K., Vaughn V.T., Ashe W.K., Markovic B., Djuric V., Jankovic B.D. Gestational exposure to loud noise alters the development and postnatal responsiveness of humoral and cellular components of the immune system in offspring. Environ Res 1997, 73(1-2):227-241.
34. Spyker J.M. Assessing the impact of low level chemicals on development: behavioral and latent effects. Fed Proc 1975, 34(9):1835-1844.
35. Tuchscherer M., Kanitz E., Otten W., Tuchscherer A. Effects of prenatal stress on cellular and humoral immune responses in neonatal pigs. Vet Immunol Immunopathol 2002, 86(3-4):195-203.
36. Gotz A.A., Stefanski V. Psychosocial maternal stress during pregnancy affects serum corticosterone, blood immune parameters and anxiety behaviour in adult male rat offspring. Physiol Behav 2007, 90(1):108-115.
37. Gotz A.A., Wittlinger S., Stefanski V. Maternal social stress during pregnancy alters immune function and immune cell numbers in adult male Long-Evans rat offspring during stressful life-events. J Neuroimmunol 2007, 185(1-2):95-102.
38. Entringer S., Kumsta R., Nelson E.L., Hellhammer D.H., Wadhwa P.D., Wü S. Influence of prenatal psychosocial stress on cytokine production in adult women. Dev Psychobiol 2008, 50:579-587.
39. Sawyer R., Hendrickx A., Osburn B., Terrell T., Anderson J. Abnormal morphology of the fetal monkey (Macaca mulatta) thymus exposed to a corticosteroid. J Med Primatol 1977, 6(3):145-150.
40. Collinson A.C., Moore S.E., Cole T.J., Prentice A.M. Birth season and environmental influences on patterns of thymic growth in rural Gambian infants. Acta Paediatr 2003, 92(9):1014-1020.
41. Naeye R.L., Diener M.L., Harcke H.T., Blang W.A. Relation of poverty and race to birth weight and organ structure in the newborn. Pediatr Res 1971, 5:17-22.
42. McDade T.W., Beck M.A., Kuzawa C.W., Adair L.S. Prenatal undernutrition and postnatal growth are associated with adolescent thymic function. J Nutr 2001, 131(4):1225-1231.
43. Moore S.E., Jalil F., Ashraf R., Szu S.C., Prentice A.M., Hanson L.A. Birth weight predicts response to vaccination in adults born in an urban slum in Lahore, Pakistan. Am J Clin Nutr 2004, 80(2):453-459.
44. Leweke F.M., Gerth C.W., Koethe D., Klosterkotter J., Ruslanova I., Krivogorsky B., et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiat Clin Neurosci 2004, 254(1):4-8.
45. Torrey E.F., Leweke M.F., Schwarz M.J., Mueller N., Bachmann S., Schroeder J., et al. Cytomegalovirus and schizophrenia. CNS Drugs 2006, 20(11):879-885.
46. Harris E.C., Barraclough B. Excess mortality of mental disorder. Br J Psychiat 1998, 173:11-53.
47. Müller N., Riedel M., Ackenheil M., Schwarz M.J. The role of immune function in schizophrenia: an overview. Eur Arch Psychiat Clin Neurosci 1999, 249(Suppl. 4):62-68.
48. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 2006, 27(2):71-80.
49. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res 1998, 32(1):9-15.
50. Abdeljaber M.H., Nair M.P., Schork M.A., Schwartz S.A. Depressed natural killer cell activity in schizophrenic patients. Immunol Invest 1994, 23(4-5):259-268.
51. Brix T.H., Kyvik K.O., Christensen K., Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001, 86(2):930-934.
52. Rose N.R. Mechanisms of autoimmunity. Semin Liver Dis 2002, 22(4):387-394.
53. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiat 2006, 163(3):521-528.
54. Wright P., Sham P.C., Gilvarry C.M., Jones P.B., Cannon M., Sharma T., et al. Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophr Res 1996, 20(3):261-267.
55. Fairweather D., Rose N.R. Type 1 diabetes: virus infection or autoimmune disease?. Nat Immunol 2002, 3(4):338-340.
56. Regner M., Lambert P.H. Autoimmunity through infection or immunization?. Nat Immunol 2001, 2(3):185-188.
57. Oldstone M.B.A. Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 2005, 296:1-17.
58. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007, 204(12):2899-2912.
59. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis: part I: the role of infection. Ann Neurol 2007, 61:288-299.
60. Cannell J.J., Hollis B.W., Zasloff M., Heaney R.P. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2009, 9(1):1-12.
61. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?. Schizophr Res 1999, 40(3):173-177.
62. Schneider B., Weber B., Frensch A., Stein J., Fritze J. Vitamin D in schizophrenia, major depression, and alcoholism. J Neural Transm 2000, 107:839-842.
63. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296(23):2832-2838.
64. Lewis G., David A., Andreasson S., Alleback P. Schizophrenia and city life (see comments). Lancet 1992, 340(8812):137-140.
65. Mortensen P.B., Pedersen C.B., Westergaard T., Wohlfahrt J., Ewald H., et al. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med 1999, 340(8):603-608.
66. Torrey E.F., Bowler A.E., Clark K. Urban birth and residence as risk factors for psychosis: an analysis of 1880 data. Schizophr Res 1997, 25(3):169-176.
67. Brims F., Chauhan A.J. Air quality, tobacco smoke, urban crowding and day care: modern menaces and their effects on health. Pediatr Infect Dis J 2005, 24(Suppl. 11):S152-S156. discussion S156-7.
68. Harpham T., Stephens C. Urbanization and health in developing countries. World Health Stat Q 1991, 44(2):62-69.
69. Marcelis M., Navarro-Mateu F., Murray R., Selten J.P., van Os J. Urbanization and psychosis: a study of 1942-1978 birth cohorts in The Netherlands. Psychol Med 1998, 28(4):871-879.
70. van Os J., Hanssen M., Bijl R.V., Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiat 2001, 58(7):663-668.
71. van Os J., Hanssen M., de Graaf R., Vollebergh W. Does the urban environment independently increase the risk for both negative and positive features of psychosis?. Soc Psychiat Psychiatr Epidemiol 2002, 37(10):460-464.
72. Eaton W., Harrison G. Ethnic disadvantage and schizophrenia. Acta Psychiatr Scand 2000, 407:38-43.
73. Cannell J.J., Vieth R., Umhau J.C., et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006, 134:1129-1140.
74. Adams J.S., Liu P.T., Chun R., Modlin R.L., Hewison M. Vitamin D in defense of the human immune response. Ann NY Acad Sci 2007, 1117:94-105.
75. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97(1-2):93-101.
76. Dawodu A., Wagner C.L. Mother-child vitamin D deficiency: an international perspective. Arch Dis Child 2007, 92:737-740.
77. Møller A.P., Sorci G., Erritzoe J. Sexual dimorphism in immune defense. Am Nat 1998, 152(4):605-619.
78. Billingham R.E. Immunologic advantages and disadvantages of being female. Reproductive immunology 1986, 1-9. Elsevier, New York. B.A. Croy, D.A. Clark (Eds.).
79. Goble F.C., Kanopka E.A. Sex as a factor in infectious disease. Trans NY Acad Sci 1973, 35:325-346.
80. Klein S.L. Hormones and mating system affect sex and species differentiation in immune function. Behav Proc 2000, 51(1-3):149-166.
81. Butterworth M.B., McClennan B., Alansmith M. Influence of sex on immunoglobulin levels. Nature 1967, 214:1224-1225.
82. Eideinger D., Garrett T.J. Studies of the regulatory effects of sex hormones on antibody formation and stem cell differentiation. J Exp Med 1972, 136:1098-1116.
83. Schuurs A.H., Verheul H.A. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990, 35(2):157-172.
84. Blazkovec A.A., Orsini M.W. Ontogenetic aspects of sexual dimorphism and the primary immune response to sheep erythrocytes in hamsters from prepuberty through senescence. Int Arch Allergy Appl Immunol 1976, 50(1):55-67.
85. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003, 28:17-53.
86. Gottesman I.I. Schizophrenia genesis: the origins of madness 1991, Henry Holt & Co, Inc., New York.
87. Stefansson H., Rujescu D., Cichon S., et al. Large recurrent microdeletions in schizophrenia. Nature 2008, 455:232-237.
88. Lencz T., Morgan T.V., Athanasiou M., et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatr 2007, 12:572-580.
89. Nuechterlein K.H., Dawson M.E., Gitlin M., Ventura J., Goldstein M.J., Snyder K.S., et al. Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992, 18(3):387-425.
90. Nuechterlein K.H., Dawson M.E. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1986, 10:300-312.
91. van Winkel R., Stephanis N.C., Myin-Germeys I. Psychosocial stress and psychosis: a review of the neurobiological mechanism and the evidence for gene-stress interaction. Schizophr Bull 2008, 34(6):1095-1105.
92. Brown G.W., Birley J.L.T. Viruses and life changes and the onset of schizophrenia. J Health Soc Behav 1968, 9:203-214.
93. Day R., Nielsen J.A., Korten A., Ernberg G., Dube K.C., Gebhart J., et al. Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization. Cult Med Psychiat 1987, 11(2):123-205.
94. Ventura J., Nuechterlein K.H., Lukoff D., Hardesty J.P. A prospective study of stressful life events and schizophrenic relapse. J Abnorm Psychol 1989, 98(4):407-411.
95. Norman R.M., Malla A.K. A prospective study of daily stressors and symptomatology in schizophrenic patients. Soc Psychiat Psychiatr Epidemiol 1994, 29(6):244-249.
96. Norman R.M., Malla A.K. Family history of schizophrenia and the relationship of stress to symptoms: preliminary findings. Aust NZ J Psychiat 2001, 35(2):217-223.
97. Myin-Germeys I., Delespaul P., van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med 2005, 35(5):733-741.
98. Norman R.M., Malla A.K., McLean T.S., McIntosh E.M., Neufeld R.W., Voruganti L.P., et al. An evaluation of a stress management program for individuals with schizophrenia. Schizophr Res 2002, 58(2-3):293-303.
99. Walker E., Mittal V., Tessner K. Stress and the hypothalmic pituitary adrenal axis in the developmental course of schizophrenia. Ann Rev Clin Psychol 2008, 4:189-216.
100. Yang E.V., Glaser R. Stress-induced immunomodulation and the implications for health. Int Immunopharmacol 2002, 2(2-3):315-324.
101. Godbout J.P., Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol 2006, 1(4):421-427.
102. Kemeny M.E., Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun 2007, 21(8):1009-1018.
103. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. PNAS USA 2003, 100:9090-9095.
104. Jones-Brando L., Torrey E.F., Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003, 62(3):237-244.
105. Zhu S., Lun Z.R. Psychosis may be associated with toxoplasmosis. Med Hypotheses 2009, 73(5):799-801.
106. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 2006, 273(1589):1023-1030.
107. Amaral L., Viveiros M., Kristiansen J.E. "Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries. Curr Drug Targets 2006, 7(7):887-891.
108. Amaral L., Martins M., Viveiros M. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 2007, 59(6):1237-1246.
109. Bettencourt M.V., Bosne-David S., Amaral L. Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents 2000, 16(1):69-71.
110. Thanacoody H.K.H. Thioridazine: resurrection as an antimicrobial agent?. Br J Clin Pharmacol 2007, 64(5):566-574.
111. Jeyaseeli L., Gupta A.D., Asok Kumar K., et al. Antimicrobial potentiality of thioxanthene flupenthixol through intensive in vitro and in vivo experiments. Int J Antimicrob Agents 2006, 27(1):58-62.
112. Maino K., Gruber R., Riedel M., Seitz N., Schwarz M., Müller N. T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiat Res 2007, 152(2-3):173-180.
113. Altshuler E.L., Kast R.E. Using histamine (HI) antagonists, in particular antipsychotics, to treat anemia of chronic disease via interleukin-6 suppression. Med Hypotheses 2005, 65:65-67.
114. Sen P., Barton S.E. Genital herpes and its management. BMJ 2007, 4(7602):1048-1052.
115. Bennekov T., Spector D., Langhoff E. Induction of immunity against human cytomegalovirus. Mt Sinai J Med 2004, 71(2):86-93.
116. Rodriguez M., Zoecklein L., Gamez J.D., Pavelko K.D., Papke L.M., Nakane S., et al. STAT4- and STAT6-signaling molecules in a murine model of multiple sclerosis. FASEB J 2006, 20(2):343-345.
117. DeLorenze G.N., Munger K.L., Lennette E.T., Orentreich N., Vogelman J.H., Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006, 63:839-844.
118. McGrath J. Comment on Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis, ; 2007 [accessed 27.02.09]. http://schizophreniaforum.org/for/live/detailprint.asp?liveID=56.
119. Hinze-Selch D., Däubener W., Eggert L., Erdag S., Stoltenberg R., Wilms S. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull 2007, 33(3):782-788.
120. Salisbury D.F., Kuroki N., Kasai K., Shenton M.E., McCarley R.W. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiat 2007, 64(5):521-529.
121. Yoshida T., McCarley R.W., Nakamura M., et al. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res 2009, 113:84-94.
122. Fan X.D., Pristach C., Liu E.Y., Freudenreich O., Henderson D.C., Goff D.C. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiat Res 2007, 149(1-3):267-271.
123. Nilsson L.K., Linderholm K.R., Erhardt S. Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons. J Neural Transm 2006, 113(5):557-571.
124. Ceresoli-Borroni G., Rassoulpour A., Wu H.Q., Guidetti P., Schwarcz R. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain. J Neural Transm 2006, 113(10):1355-1365.
125. Das I., Khan N.S. Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects. Prostagl Leukot Essent Fatty Acids 1998, 58(3):165-168.
126. Mizuno M., Sotoyama H., Narita E., Kawamura H., Namba H., Zheng Y., et al. A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. J Neurosci 2007, 27(38):10116-10127.
127. Müller N., Riedel M., Scheppach C., Brandstätter B., Sokkullu S., Krampe K., et al. Beneficial anti-psychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiat 2002, 159:1029-1034.
128. Müller N., Ulmschneider M., Möller H.-J., Gruber R., Riedel M. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur Arch Psychiat Clin Neurosci 2004, 254:14-22.
129. Garver D.L., Tamas R.L., Holcomb J.A. Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 2003, 28(8):1515-1520.
130. Monji A., Kato T., Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiat Clin Neurosci 2009, 63(3):257-265.
131. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiat Res 1982, 17(4):319-334.
132. Kiecolt-Glaser J.K. Psychology's gateway to the biomedical future. Perspect Psychol Sci 2009, 4(4):367-369.
133. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 2009, 35(5):959-972.
134. Van Lieshout R.J., Voruganti L.P. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms. J Psychiat Neurosci 2008, 33(5):395-404.
135. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005, 29:913-947.
136. Buka S.L., Tsuang M.T., Torrey E.F. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001, 15:411-420.